Activated ClpP kills persisters and eradicates a chronic biofilm infection

B. P. Conlon, E. S. Nakayasu, L. E. Fleck, M. D. LaFleur, V. M. Isabella, K. Coleman, S. N. Leonard, R. D. Smith, J. N. Adkins and K. Lewis ()
Additional contact information
B. P. Conlon: Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts 02115, USA
E. S. Nakayasu: Pacific Northwest National Laboratory, Richland, Washington 99352, USA
L. E. Fleck: Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts 02115, USA
M. D. LaFleur: Arietis Corporation, Boston, Massachusetts 02118, USA
V. M. Isabella: Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts 02115, USA
K. Coleman: Arietis Corporation, Boston, Massachusetts 02118, USA
S. N. Leonard: Bouvé College of Health Sciences, School of Pharmacy, Northeastern University, Boston, Massachusetts 02115, USA
R. D. Smith: Pacific Northwest National Laboratory, Richland, Washington 99352, USA
J. N. Adkins: Pacific Northwest National Laboratory, Richland, Washington 99352, USA
K. Lewis: Antimicrobial Discovery Center, Northeastern University, Boston, Massachusetts 02115, USA

Nature, 2013, vol. 503, issue 7476, 365-370

Abstract: Abstract Chronic infections are difficult to treat with antibiotics but are caused primarily by drug-sensitive pathogens. Dormant persister cells that are tolerant to killing by antibiotics are responsible for this apparent paradox. Persisters are phenotypic variants of normal cells and pathways leading to dormancy are redundant, making it challenging to develop anti-persister compounds. Biofilms shield persisters from the immune system, suggesting that an antibiotic for treating a chronic infection should be able to eradicate the infection on its own. We reasoned that a compound capable of corrupting a target in dormant cells will kill persisters. The acyldepsipeptide antibiotic (ADEP4) has been shown to activate the ClpP protease, resulting in death of growing cells. Here we show that ADEP4-activated ClpP becomes a fairly nonspecific protease and kills persisters by degrading over 400 proteins, forcing cells to self-digest. Null mutants of clpP arise with high probability, but combining ADEP4 with rifampicin produced complete eradication of Staphylococcus aureus biofilms in vitro and in a mouse model of a chronic infection. Our findings indicate a general principle for killing dormant cells—activation and corruption of a target, rather than conventional inhibition. Eradication of a biofilm in an animal model by activating a protease suggests a realistic path towards developing therapies to treat chronic infections.

Date: 2013
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
https://www.nature.com/articles/nature12790 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:503:y:2013:i:7476:d:10.1038_nature12790

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/nature12790

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().